Page last updated: 2024-08-22

cobaltous chloride and Heart Diseases

cobaltous chloride has been researched along with Heart Diseases in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Han, Y; Jing, Q; Mei, Z; Song, H; Tang, Y; Wu, H; Yan, B; Yan, C; Zhang, X1
Ajibade, T; Akinrinde, AS; Asenuga, E; Omobowale, O; Oyagbemi, A1
Liu, F; Liu, YK; Tao, R; Xu, H; Yin, J1

Other Studies

3 other study(ies) available for cobaltous chloride and Heart Diseases

ArticleYear
FGF21-FGFR1 controls mitochondrial homeostasis in cardiomyocytes by modulating the degradation of OPA1.
    Cell death & disease, 2023, 05-08, Volume: 14, Issue:5

    Topics: Animals; Fibroblast Growth Factors; Heart Diseases; Homeostasis; Mice; Mice, Knockout; Myocytes, Cardiac

2023
Protective effects of kolaviron and gallic acid against cobalt-chloride-induced cardiorenal dysfunction via suppression of oxidative stress and activation of the ERK signaling pathway.
    Canadian journal of physiology and pharmacology, 2016, Volume: 94, Issue:12

    Topics: Acute Kidney Injury; Animals; Antioxidants; Cobalt; Drug Therapy, Combination; Flavonoids; Gallic Acid; Garcinia kola; Heart Diseases; Male; MAP Kinase Signaling System; Oxidative Stress; Plant Extracts; Protective Agents; Rats; Rats, Wistar; Seeds

2016
Effects of serum cobalt ion concentration on the liver, kidney and heart in mice.
    Orthopaedic surgery, 2010, Volume: 2, Issue:2

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cobalt; Disease Models, Animal; Dose-Response Relationship, Drug; Heart Diseases; Hepatocytes; Joint Prosthesis; Kidney; Kidney Diseases; Male; Mice; Mice, Inbred ICR; Microscopy, Electron; Myocytes, Cardiac

2010